Coya Therapeutics (COYA) Profit After Tax (2022 - 2026)

Coya Therapeutics has reported Profit After Tax for 5 years, with the latest figure at -$7.2 million in Q1 2026.

• Quarterly Profit After Tax rose 1.37% year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.1 million (down 23.29% YoY) and the FY2025 annual result came in at -$21.2 million, down 42.64% from the prior year.
• Profit After Tax fell to -$7.2 million in Q1 2026 per COYA's latest filing, from -$5.7 million in the prior quarter.
• Over five years, Profit After Tax peaked at $1.3 million in Q4 2023 and troughed at -$7.3 million in Q1 2025.
• A 5-year average of -$3.7 million and a median of -$3.4 million in 2022 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax jumped 140.74% in 2023, then slumped 330.32% in 2024.
• Over 5 years, Profit After Tax stood at -$3.1 million in 2022, then jumped by 140.74% to $1.3 million in 2023, then plunged by 330.32% to -$2.9 million in 2024, then slumped by 95.78% to -$5.7 million in 2025, then retreated by 26.25% to -$7.2 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$7.2 million, -$5.7 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.